Background Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory support devices acutely improve hemodynamic conditions. Objectives The aim of this study was to determine whether a new percutaneous mechanical circulatory support (pMCS) device (Impella CP, Abiomed, Danvers, Massachusetts) decreases 30-day mortality when compared with an intra-aortic balloon pump (IABP) in patients with severe shock complicating AMI. Methods In a randomized, prospective, open-label, multicenter trial, 48 patients with severe CS complicating AMI were assigned to pMCS (n = 24) or IABP (n = 24). Severe CS was defined as systolic blood pressure <90 mm Hg ...
Although intra-aortic balloon pump (IABP) counterpulsation is increasingly being used for the treatm...
International audienceBACKGROUND: Percutaneous assist devices may be used as a bridge to recovery in...
International audienceBACKGROUND: Percutaneous assist devices may be used as a bridge to recovery in...
Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiog...
Background Historically, the intra-aortic balloon pump (IABP) has been the primary means of providin...
Cardiogenic shock is the most common cause of death in patients with acute myocardial infarction. Ar...
OBJECTIVES: Mortality rates in patients with acute myocardial infarction and cardiogenic shock (AMI-...
BACKGROUND: Percutaneous mechanical circulatory support devices are increasingly used in acute myoca...
Background The relative safety of percutaneous left ventricular assist device (pVAD) and intra-aorti...
Cardiogenic shock complicating acute MI carries high mortality and morbidity in many cases. Mechanic...
SummaryBackgroundIn patients with acute myocardial infarction (MI), cardiogenic shock (CS) remains a...
Background: Despite recent advances in the management of heart failure, cardiogenic shock remains a ...
Background\ud In the current international guidelines, intra-aortic balloon pump (IABP) counterpulsa...
Prior studies have suggested intraaortic balloon pump (IABP) have a neutral effect on acute myocardi...
<div><p>Background</p><p>Prior studies have suggested intraaortic balloon pump (IABP) have a neutral...
Although intra-aortic balloon pump (IABP) counterpulsation is increasingly being used for the treatm...
International audienceBACKGROUND: Percutaneous assist devices may be used as a bridge to recovery in...
International audienceBACKGROUND: Percutaneous assist devices may be used as a bridge to recovery in...
Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiog...
Background Historically, the intra-aortic balloon pump (IABP) has been the primary means of providin...
Cardiogenic shock is the most common cause of death in patients with acute myocardial infarction. Ar...
OBJECTIVES: Mortality rates in patients with acute myocardial infarction and cardiogenic shock (AMI-...
BACKGROUND: Percutaneous mechanical circulatory support devices are increasingly used in acute myoca...
Background The relative safety of percutaneous left ventricular assist device (pVAD) and intra-aorti...
Cardiogenic shock complicating acute MI carries high mortality and morbidity in many cases. Mechanic...
SummaryBackgroundIn patients with acute myocardial infarction (MI), cardiogenic shock (CS) remains a...
Background: Despite recent advances in the management of heart failure, cardiogenic shock remains a ...
Background\ud In the current international guidelines, intra-aortic balloon pump (IABP) counterpulsa...
Prior studies have suggested intraaortic balloon pump (IABP) have a neutral effect on acute myocardi...
<div><p>Background</p><p>Prior studies have suggested intraaortic balloon pump (IABP) have a neutral...
Although intra-aortic balloon pump (IABP) counterpulsation is increasingly being used for the treatm...
International audienceBACKGROUND: Percutaneous assist devices may be used as a bridge to recovery in...
International audienceBACKGROUND: Percutaneous assist devices may be used as a bridge to recovery in...